top of page
Member of cross-functional team charged with mapping out a broad companywide complement therapeutic strategy and indication selection/early development strategies for pipeline molecules. Lead collaborative initiatives with external researchers to optimize or develop diagnostic and other complement-based assays for key indications. Lead collaborative initiatives for strategic Phase 4 clinical studies. Work with BD to evaluate investment opportunities and emerging technologies.
bottom of page